BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20039876)

  • 21. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics.
    Ho WT; Chang JS; Chou SF; Hwang WL; Shih PJ; Chang SW; Yang MH; Jou TS; Wang IJ
    J Mol Med (Berl); 2019 Sep; 97(9):1345-1357. PubMed ID: 31302714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis.
    Melton AC; Yee HF
    Hepatology; 2007 Jun; 45(6):1446-53. PubMed ID: 17465006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An inhibitor of myosin II, blebbistatin, suppresses development of arterial thrombosis.
    Zhang Y; Li L; Zhou Q; Li W; Li M; Guo G; Yu B; Kou J
    Biomed Pharmacother; 2020 Feb; 122():109775. PubMed ID: 31918291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stellate cell contraction: role, regulation, and potential therapeutic target.
    Soon RK; Yee HF
    Clin Liver Dis; 2008 Nov; 12(4):791-803, viii. PubMed ID: 18984467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contractility in type III cochlear fibrocytes is dependent on non-muscle myosin II and intercellular gap junctional coupling.
    Kelly JJ; Forge A; Jagger DJ
    J Assoc Res Otolaryngol; 2012 Aug; 13(4):473-84. PubMed ID: 22476723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of polarity in cells devoid of actin bundle system after treatment with inhibitors of myosin II activity.
    Shutova MS; Alexandrova AY; Vasiliev JM
    Cell Motil Cytoskeleton; 2008 Sep; 65(9):734-46. PubMed ID: 18615701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myosin phosphatase targeting subunit 1 affects cell migration by regulating myosin phosphorylation and actin assembly.
    Xia D; Stull JT; Kamm KE
    Exp Cell Res; 2005 Apr; 304(2):506-17. PubMed ID: 15748895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmuscle myosin II is responsible for maintaining endothelial cell basal tone and stress fiber integrity.
    Goeckeler ZM; Bridgman PC; Wysolmerski RB
    Am J Physiol Cell Physiol; 2008 Oct; 295(4):C994-1006. PubMed ID: 18701651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Block the function of nonmuscle myosin II by blebbistatin induces zebrafish embryo cardia bifida.
    Wang X; Chong M; Wang X; Wang H; Zhang J; Xu H; Zhang J; Liu D
    In Vitro Cell Dev Biol Anim; 2015 Mar; 51(3):211-7. PubMed ID: 25403653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts.
    Fedorov VV; Lozinsky IT; Sosunov EA; Anyukhovsky EP; Rosen MR; Balke CW; Efimov IR
    Heart Rhythm; 2007 May; 4(5):619-26. PubMed ID: 17467631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of blebbistatin inhibition of myosin II.
    Kovács M; Tóth J; Hetényi C; Málnási-Csizmadia A; Sellers JR
    J Biol Chem; 2004 Aug; 279(34):35557-63. PubMed ID: 15205456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blebbistatin stabilizes the helical order of myosin filaments by promoting the switch 2 closed state.
    Zhao FQ; Padrón R; Craig R
    Biophys J; 2008 Oct; 95(7):3322-9. PubMed ID: 18599626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Selective Myosin II Inhibitor Blebbistatin Reversibly Eliminates Gastrovascular Flow and Stolon Tip Pulsations in the Colonial Hydroid Podocoryna carnea.
    Connally N; Anderson CP; Bolton JE; Bolton EW; Buss LW
    PLoS One; 2015; 10(11):e0143564. PubMed ID: 26605798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.
    Xu W; Lu C; Zhang F; Shao J; Zheng S
    IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blebbistatin and blebbistatin-inactivated myosin II inhibit myosin II-independent processes in Dictyostelium.
    Shu S; Liu X; Korn ED
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1472-7. PubMed ID: 15671182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blebbistatin, a myosin II inhibitor, is photoinactivated by blue light.
    Sakamoto T; Limouze J; Combs CA; Straight AF; Sellers JR
    Biochemistry; 2005 Jan; 44(2):584-8. PubMed ID: 15641783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calponin 3 regulates stress fiber formation in dermal fibroblasts during wound healing.
    Daimon E; Shibukawa Y; Wada Y
    Arch Dermatol Res; 2013 Sep; 305(7):571-84. PubMed ID: 23545751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs.
    Verhasselt S; Stevens CV; Van den Broecke T; Bracke ME; Roman BI
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2986-2989. PubMed ID: 28512027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease.
    Si J; Ge Y; Zhuang S; Gong R
    Lab Invest; 2010 Mar; 90(3):448-58. PubMed ID: 20065948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.
    Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J
    J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.